BRWM
MREO

Blue Rock Wealth Management’s Mereo BioPharma MREO Stock Holding History

Blue Rock Wealth Management’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.27K Hold
19,000
– – ﹤0.01% 103
2025
Q4 		$7.92K Sell
19,000
-18,000
-49% -$34.3K ﹤0.01% 105
2025
Q3 		$76.2K Hold
37,000
– – 0.05% 104
2025
Q2 		$100K Buy
+37,000
New +$89.3K 0.07% 100

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Blue Rock Wealth Management's MREO Position: Q1 2026 in Review

Blue Rock Wealth Management held its Mereo BioPharma (MREO) position steady in Q1 2026 at 19,000 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #103.

Blue Rock Wealth Management first reported a position in MREO in Q2 2025 and has held it in 4 quarters since. The position peaked at $100K in Q2 2025. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

  • Blue Rock Wealth Management held 19,000 shares of Mereo BioPharma worth $6.27K as of Q1 2026.
  • Blue Rock Wealth Management left its Mereo BioPharma share count unchanged in Q1 2026.
  • Mereo BioPharma made up ﹤0.01% of Blue Rock Wealth Management's portfolio in Q1 2026, its #103 holding.
  • Blue Rock Wealth Management first reported a position in Mereo BioPharma in Q2 2025 and has held it in 4 quarters since.
  • Blue Rock Wealth Management's Mereo BioPharma position peaked at $100K in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on Blue Rock Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.